Michael A. Postow

1. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
   2018/01/10 by Michael A. Postow, Robert Sidlow, Matthew D. Hellmann · 30 citations
   Medicine · Immunology and Microbiology · #Cancer Immunotherapy and Biomarkers #Immune Cell Function and Interaction #Colorectal Cancer Treatments and Studies
2. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
   2015/05/31 by James Larkin, Vanna Chiarion‐Sileni, Vanna Chiarion-Sileni +37 · 26 citations
   Medicine · Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · #Cancer Immunotherapy and Biomarkers #Melanoma and MAPK Pathways #Immunotherapy and Immune Responses
3. Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma
   2025/07/10 by Elizabeth M. Burton, Denái R. Milton, Michael T. Tetzlaff +25 · 11 citations
   Medicine · #Cancer Immunotherapy and Biomarkers #Cutaneous Melanoma Detection and Management #CAR-T cell therapy research